Literature DB >> 27683550

Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection.

Maximilian Muenchhoff1, Emily Adland2, Owen Karimanzira3, Carol Crowther3, Matthew Pace4, Anna Csala2, Ellen Leitman2, Angeline Moonsamy2, Callum McGregor5, Jacob Hurst6, Andreas Groll7, Masahiko Mori2, Smruti Sinmyee2, Christina Thobakgale8, Gareth Tudor-Williams9, Andrew J Prendergast10, Henrik Kloverpris11, Julia Roider12, Alasdair Leslie13, Delane Shingadia14, Thea Brits15, Samantha Daniels15, John Frater4, Christian B Willberg16, Bruce D Walker17, Thumbi Ndung'u18, Pieter Jooste15, Penny L Moore19, Lynn Morris19, Philip Goulder20.   

Abstract

Disease-free infection in HIV-infected adults is associated with human leukocyte antigen-mediated suppression of viremia, whereas in the sooty mangabey and other healthy natural hosts of simian immunodeficiency virus (SIV), viral replication continues unabated. To better understand factors preventing HIV disease, we investigated pediatric infection, where AIDS typically develops more rapidly than in adults. Among 170 nonprogressing antiretroviral therapy-naïve children aged >5 years maintaining normal-for-age CD4 T cell counts, immune activation levels were low despite high viremia (median, 26,000 copies/ml). Potent, broadly neutralizing antibody responses in most of the subjects and strong virus-specific T cell activity were present but did not drive pediatric nonprogression. However, reduced CCR5 expression and low HIV infection in long-lived central memory CD4 T cells were observed in pediatric nonprogressors. These children therefore express two cardinal immunological features of nonpathogenic SIV infection in sooty mangabeys-low immune activation despite high viremia and low CCR5 expression on long-lived central memory CD4 T cells-suggesting closer similarities with nonpathogenetic mechanisms evolved over thousands of years in natural SIV hosts than those operating in HIV-infected adults.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27683550      PMCID: PMC6087524          DOI: 10.1126/scitranslmed.aag1048

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  62 in total

Review 1.  Residual immune dysregulation syndrome in treated HIV infection.

Authors:  Michael M Lederman; Nicholas T Funderburg; Rafick P Sekaly; Nichole R Klatt; Peter W Hunt
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

2.  Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Authors:  Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek
Journal:  J Infect Dis       Date:  2011-01-20       Impact factor: 5.226

3.  The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection.

Authors:  Elin S Gray; Maphuti C Madiga; Tandile Hermanus; Penny L Moore; Constantinos Kurt Wibmer; Nancy L Tumba; Lise Werner; Koleka Mlisana; Sengeziwe Sibeko; Carolyn Williamson; Salim S Abdool Karim; Lynn Morris
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

4.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

5.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

6.  Profile of T cell immune responses in HIV-infected children from Uganda.

Authors:  Isaac Ssewanyana; Mohamed Elrefaei; Grant Dorsey; Theodore Ruel; Norman G Jones; Anne Gasasira; Moses Kamya; Justine Nakiwala; Jane Achan; Edwin Charlebois; Diane Havlir; Huyen Cao
Journal:  J Infect Dis       Date:  2007-10-25       Impact factor: 5.226

7.  Target cell availability, rather than breast milk factors, dictates mother-to-infant transmission of SIV in sooty mangabeys and rhesus macaques.

Authors:  Ann Chahroudi; Emily Cartwright; S Thera Lee; Maud Mavigner; Diane G Carnathan; Benton Lawson; Paul M Carnathan; Tayebeh Hashempoor; Megan K Murphy; Tracy Meeker; Stephanie Ehnert; Christopher Souder; James G Else; Joyce Cohen; Ronald G Collman; Thomas H Vanderford; Sallie R Permar; Cynthia A Derdeyn; Francois Villinger; Guido Silvestri
Journal:  PLoS Pathog       Date:  2014-03-06       Impact factor: 6.823

8.  HIV-1 DNA predicts disease progression and post-treatment virological control.

Authors:  James P Williams; Jacob Hurst; Wolfgang Stöhr; Nicola Robinson; Helen Brown; Martin Fisher; Sabine Kinloch; David Cooper; Mauro Schechter; Giuseppe Tambussi; Sarah Fidler; Mary Carrington; Abdel Babiker; Jonathan Weber; Kersten K Koelsch; Anthony D Kelleher; Rodney E Phillips; John Frater
Journal:  Elife       Date:  2014-09-12       Impact factor: 8.140

9.  Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth.

Authors:  Maja Kiselinova; Ward De Spiegelaere; Maria Jose Buzon; Eva Malatinkova; Mathias Lichterfeld; Linos Vandekerckhove
Journal:  PLoS Pathog       Date:  2016-03-03       Impact factor: 6.823

10.  High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis.

Authors:  Wendy Mphatswe; Natasha Blanckenberg; Gareth Tudor-Williams; Andrew Prendergast; Christina Thobakgale; Nompumelelo Mkhwanazi; Noel McCarthy; Bruce D Walker; Photini Kiepiela; Philip Goulder
Journal:  AIDS       Date:  2007-06-19       Impact factor: 4.177

View more
  62 in total

1.  Immunological mechanisms of inducing HIV immunity in infants.

Authors:  Genevieve G Fouda; Kristina De Paris; Ofer Levy; Arnaud Marchant; Glenda Gray; Sallie Permar; Mary Marovich; Anjali Singh
Journal:  Vaccine       Date:  2019-11-21       Impact factor: 3.641

Review 2.  Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure.

Authors:  Stella J Berendam; Ashley N Nelson; Ria Goswami; Deborah Persaud; Nancy L Haigwood; Ann Chahroudi; Genevieve G Fouda; Sallie R Permar
Journal:  Curr HIV/AIDS Rep       Date:  2020-06       Impact factor: 5.071

3.  Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans.

Authors:  Gemma W Koor; Maria Paximadis; Anabela C P Picton; Fidan Karatas; Shayne A Loubser; Weijing He; Sunil K Ahuja; Richard E Chaisson; Neil Martinson; Osman Ebrahim; Caroline T Tiemessen
Journal:  Clin Immunol       Date:  2019-05-15       Impact factor: 3.969

4.  Cognition, Emotional Health, and Immunological Markers in Children With Long-Term Nonprogressive HIV.

Authors:  Robert Paul; Tanakorn Apornpong; Wasana Prasitsuebsai; Thanyawee Puthanakit; Vonthanak Saphonn; Linda Aurpibul; Pope Kosalaraksa; Suparat Kanjanavanit; Wicharn Luesomboon; Chaiwat Ngampiyaskul; Tulathip Suwanlerk; Kea Chettra; William T Shearer; Victor Valcour; Jintanat Ananworanich; Stephen Kerr
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-01       Impact factor: 3.731

5.  CXCR6 gene characterization in two ethnically distinct South African populations and association with viraemic disease control in HIV-1-infected black South African individuals.

Authors:  Anabela C P Picton; Maria Paximadis; Richard E Chaisson; Neil A Martinson; Caroline T Tiemessen
Journal:  Clin Immunol       Date:  2017-04-18       Impact factor: 3.969

Review 6.  The Neutralizing Antibody Response to the HIV-1 Env Protein.

Authors:  Penny L Moore
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

7.  An HIV-1 Broadly Neutralizing Antibody from a Clade C-Infected Pediatric Elite Neutralizer Potently Neutralizes the Contemporaneous and Autologous Evolving Viruses.

Authors:  Harekrushna Panda; Muzamil Ashraf Makhdoomi; Nitesh Mishra; Sanjeev Kumar; Haaris Ahsan Safdari; Himanshi Chawla; Heena Aggarwal; Elluri Seetharami Reddy; Rakesh Lodha; Sushil Kumar Kabra; Anmol Chandele; Somnath Dutta; Kalpana Luthra
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 8.  The antibody response in HIV-1-infected donors.

Authors:  Simone I Richardson; Penny L Moore
Journal:  Curr Opin HIV AIDS       Date:  2019-07       Impact factor: 4.283

Review 9.  Cross-reactivity of HIV vaccine responses and the microbiome.

Authors:  Wilton B Williams; Qifeng Han; Barton F Haynes
Journal:  Curr Opin HIV AIDS       Date:  2018-01       Impact factor: 4.283

10.  Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes.

Authors:  Ashley N Nelson; Ria Goswami; Maria Dennis; Joshua Tu; Riley J Mangan; Pooja T Saha; Derek W Cain; Alan D Curtis; Xiaoying Shen; George M Shaw; Katharine Bar; Michael Hudgens; Justin Pollara; Kristina De Paris; Koen K A Van Rompay; Sallie R Permar
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.